2023
Alliance negotiation as a predictor of early treatment outcome
Manubens R, Babl A, Doran J, Roussos A, Alalu N, Penedo J. Alliance negotiation as a predictor of early treatment outcome. Journal Of Clinical Psychology 2023, 79: 1740-1751. PMID: 36806207, DOI: 10.1002/jclp.23498.Peer-Reviewed Original ResearchConceptsSymptom severityTreatment outcomesPredictors of treatment outcomeLevels of symptom severityOutcome Questionnaire 45Sessions of psychotherapyBetween-patient effectsWithin-patient effectsAlliance negotiationsHierarchical linear modelingPsychotherapy outcomeBrief therapyTherapeutic allianceEmotional disordersEarly stages of treatmentTherapy outcomeEarly treatment outcomesPsychotherapyStages of treatmentSessionsSymptomsAlliancePatient effectsSeverityTherapistsClinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder
Kiluk B, Kleykamp B, Comer S, Griffiths R, Huhn A, Johnson M, Kampman K, Pravetoni M, Preston K, Vandrey R, Bergeria C, Bogenschutz M, Brown R, Dunn K, Dworkin R, Finan P, Hendricks P, Houtsmuller E, Kosten T, Lee D, Levin F, McRae-Clark A, Raison C, Rasmussen K, Turk D, Weiss R, Strain E. Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder. JAMA Psychiatry 2023, 80: 84-92. PMID: 36449315, PMCID: PMC10297827, DOI: 10.1001/jamapsychiatry.2022.4020.Peer-Reviewed Original ResearchConceptsOpioid use disorderOUD treatmentUse disordersClinical trial design challengesAddiction Clinical Trial TranslationsΜ-opioid receptor systemNetworks (ACTTION) public-private partnershipTrial design challengesOngoing opioid epidemicTrial design considerationsClinical trial design considerationsRole of treatmentQuality of lifeAntagonist medicationsEmerging TreatmentsAdverse eventsOpioid usePrimary outcomeStages of treatmentPatient preferencesMOR agonistsOpioid epidemicConsensus recommendationsCurrent evidenceTreatment retention
2020
Challenges and opportunities for enhanced cognitive behaviour therapy (CBT-E) in light of COVID-19
Murphy R, Calugi S, Cooper Z, Dalle Grave R. Challenges and opportunities for enhanced cognitive behaviour therapy (CBT-E) in light of COVID-19. The Cognitive Behaviour Therapist 2020, 13: e14. PMID: 34191937, PMCID: PMC7264449, DOI: 10.1017/s1754470x20000161.Peer-Reviewed Original ResearchCognitive behavior therapyAspects of CBTBehavior therapyStrict social distancing rulesRemote deliveryEvidence-based treatmentsCBTPotential practical solutionFear of infectionNegative consequencesSocial isolationKey learningsSocial distancing rulesStages of treatmentPsychiatric treatmentDisordersDistancing rules
2010
Housing Preferences Among Adults with Dual Diagnoses in Different Stages of Treatment and Housing Types
Tsai J, Bond GR, Davis KE. Housing Preferences Among Adults with Dual Diagnoses in Different Stages of Treatment and Housing Types. American Journal Of Psychiatric Rehabilitation 2010, 13: 258-275. PMID: 21415937, PMCID: PMC3057217, DOI: 10.1080/15487768.2010.523357.Peer-Reviewed Original ResearchDual diagnosisSupervised housingSingle room occupancy hotelsStages of treatmentMajority of participantsSelf-report questionnairesPsychiatric rehabilitationSingle room occupancySubstance abuseConsumer housing preferencesPeer supportTreatmentSocial supportDiagnosisSite staffLower satisfactionOwn apartmentDifferent stagesReport differencesParticipants
2002
Targeted therapy in non-small-cell lung cancer.
Herbst RS. Targeted therapy in non-small-cell lung cancer. Oncology 2002, 16: 19-24. PMID: 12375797.Peer-Reviewed Original ResearchMeSH KeywordsAngiogenesis InhibitorsAntibodies, MonoclonalAntineoplastic AgentsCarcinoma, Non-Small-Cell LungClinical Trials as TopicEndothelial Growth FactorsErbB ReceptorsHumansIntercellular Signaling Peptides and ProteinsLung NeoplasmsLymphokinesProtein Kinase CVascular Endothelial Growth Factor AVascular Endothelial Growth FactorsConceptsCell lung cancerLung cancerSuch new agentsNew agentsVascular endothelial growth factor inhibitorsPlatinum-based combination therapyEGFR tyrosine kinase inhibitorsGrowth factor receptor inhibitorsNew biologic therapiesGrowth factor inhibitorsEpithelial growth factor receptor inhibitorTyrosine kinase inhibitorsSpecific biologic pathwaysDevelopment of agentsSignal transduction inhibitorsMaintenance therapyBiologic therapyCytotoxic chemotherapyStages of treatmentFactor inhibitorsCombination therapyTargeted therapyReceptor inhibitorsRadiation therapyClinical investigation
2000
Self-Help and Guided Self-Help Treatments for Bulimia Nervosa and Binge Eating Disorder
GRILO C. Self-Help and Guided Self-Help Treatments for Bulimia Nervosa and Binge Eating Disorder. Journal Of Psychiatric Practice 2000, 6: 18-26. PMID: 15990473, DOI: 10.1097/00131746-200001000-00003.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply